Immunobiology of liver xenotransplantation

Expert Review of Clinical Immunology

Volumn 8, Issue 7, 2012, Pages 621-634

  Ekser, Burcin ^a,b,c   Burlak, Christopher ^b   Waldman, Joshua P ^d   Lutz, Andrew J ^b   Paris, Leela L ^b   Veroux, Massimiliano ^c   Robson, Simon C ^e   Rees, Michael A ^d   Ayares, David ^f   Gridelli, Bruno ^a,g   Tector, A Joseph ^b   Cooper, David KC ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CATANIA   (Italy)

^d MEDICAL COLLEGE OF OHIO   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f REVIVICOR INC   (United States)

^g MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

Author keywords

1,3 galactosyltransferase gene knockout; hCD46; liver; liver failure; nonhuman primate; pig; xenotransplantation

Indexed keywords

5' NUCLEOTIDASE; AMINOCAPROIC ACID; AZATHIOPRINE; CD39 ANTIGEN; CD47 ANTIGEN; CELL PROTEIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DACLIZUMAB; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; N GLYCOLOYLNEURAMINIC ACID; RITUXIMAB; SIGNAL REGULATORY PROTEIN ALPHA; TACROLIMUS; THROMBOMODULIN; TISSUE FACTOR PATHWAY INHIBITOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ACUTE GRAFT REJECTION; ANTIGEN EXPRESSION; BABOON; CORTICOSTEROID THERAPY; ENDOTHELIUM CELL; ERYTHROCYTE; EX VIVO STUDY; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HYPERACUTE GRAFT REJECTION; IMMUNOBIOLOGY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; KUPFFER CELL; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVER XENOTRANSPLANTATION; NONHUMAN; PHAGOCYTOSIS; PRIMATE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SWINE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; WHOLE BODY RADIATION; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOOD PLATELETS; HUMANS; LIVER; LIVER TRANSPLANTATION; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84867765193     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.12.56     Document Type: Review

References (107)

1. Nguyen NT, Vierling JM. Acute liver failure. Curr. Opin. Organ Transplant. 16(3), 289-296 (2011).
2. Ekser B, Gridelli B, Tector AJ, Cooper DK. Pig liver xenotransplantation as a bridge to allotransplantation: which patients might benefit? Transplantation 88(9), 1041-1049 (2009).
3. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet 376(9736), 190-201 (2010).
4. Cooper DK, Gollackner B, Sachs DH. Will the pig solve the transplantation backlog? Annu. Rev. Med. 53, 133-147 (2002). (Pubitemid 34177875)
5. Lexer G, Cooper DK, Rose AG et al. Hyperacute rejection in a discordant (pig to baboon) cardiac xenograft model. J. Heart Transplant. 5(6), 411-418 (1986). (Pubitemid 17051978)
6. Ekser B, Cooper DK. Overcoming the barriers to xenotransplantation: Prospects for the future. Expert Rev. Clin. Immunol. 6(2), 219-230 (2010).
7. Yang YG, Sykes M. Xenotransplantation: current status and a perspective on the future. Nat. Rev. Immunol. 7(7), 519-531 (2007). (Pubitemid 46987781)
8. Good AH, Cooper DK, Malcolm AJ et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant. Proc. 24(2), 559-562 (1992).
9. Galili U, Shohet SB, Kobrin E, Stults CL, Macher BA. Man, apes, and Old World monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells. J. Biol. Chem. 263(33), 17755-17762 (1988).
10. Galili U. Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: A major obstacle for xenotransplantation in humans. Immunol. Today 14(10), 480-482 (1993). (Pubitemid 23300997)
11. Bach FH, Winkler H, Ferran C, Hancock WW, Robson SC. Delayed xenograft rejection. Immunol. Today 17(8), 379-384 (1996). (Pubitemid 26247798)
12. Schuurman HJ, Cheng J, Lam T. Pathology of xenograft rejection: A commentary. Xenotransplantation 10(4), 293-299 (2003). (Pubitemid 36903769)
13. Ekser B, Long C, Echeverri GJ et al. Impact of thrombocytopenia on survival of baboons with genetically modified pig liver transplants: clinical relevance. Am. J. Transplant. 10(2), 273-285 (2010).
14. Schuetz C, Kim K, Elias N et al. 9-day survival and control of thrombocytopenia following liver xenotransplantation in baboons using GalT-KO swine grafts. Xenotransplantation 19(4), 256-264 (2012).
15. Ezzelarab M, Hara H, Busch J et al. Antibodies directed to pig non-Gal antigens in naïve and sensitized baboons. Xenotransplantation 13(5), 400-407 (2006). (Pubitemid 44265708)
16. Cooper DK. Xenoantigens and xenoantibodies. Xenotransplantation 5(1), 6-17 (1998). (Pubitemid 28137823)
17. Chen G, Qian H, Starzl T et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat. Med. 11(12), 1295-1298 (2005). (Pubitemid 41752909)
18. Byrne GW, Stalboerger PG, Davila E et al. Proteomic identification of non-Gal antibody targets after pig-to-primate cardiac xenotransplantation. Xenotransplantation 15(4), 268-276 (2008).
19. Byrne GW, Stalboerger PG, Du Z, Davis TR, McGregor CG. Identification of new carbohydrate and membrane protein antigens in cardiac xenotransplantation. Transplantation 91(3), 287-292 (2011).
20. Burlak C, Wang ZY, Chihara RK et al. Identification of human preformed antibody targets in GTKO pigs. Xenotransplantation 19(2), 92-101 (2012).
21. Ezzelarab M, Garcia B, Azimzadeh A et al. The innate immune response and activation of coagulation in α1, 3-galactosyltransferase gene-knockout xenograft recipients. Transplantation 87(6), 805-812 (2009).
22. Makowa L, Cramer DV, Hoffman A et al. The use of a pig liver xenograft for temporary support of a patient with fulminant hepatic failure. Transplantation 59(12), 1654-1659 (1995).
23. Calne RY, White HJ, Herbertson BM et al. Pig-to-baboon liver xenografts. Lancet 1(7553), 1176-1178 (1968).
24. Calne RY, Davis DR, Pena JR et al. Hepatic allografts and xenografts in primates. Lancet 1(7638), 103-106 (1970).
25. Powelson J, Cosimi AB, Austen W Jr et al. Porcine-to-primate orthotopic liver transplantation. Transplant. Proc. 26(3), 1353-1354 (1994). (Pubitemid 24211544)
26. Luo Y, Kosanke S, Mieles L et al. Comparative histopathology of hepatic allografts and xenografts in the nonhuman primate. Xenotransplantation 5(3), 197-206 (1998). (Pubitemid 28444966)
27. Ramírez P, Chavez R, Majado M et al. Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation 70(7), 989-998 (2000).
28. Ekser B, Gridelli B, Veroux M, Cooper DK. Clinical pig liver xenotransplantation: how far do we have to go? Xenotransplantation 18(3), 158-167 (2011).
29. Ekser B, Klein E, He J et al. Geneticallyengineered pig-to-baboon liver xenotransplantation: histopathology of xenografts and native organs. PLoS ONE 7(1), e29720 (2012).
30. Ramírez P, Montoya MJ, Ríos A et al. Prevention of hyperacute rejection in a model of orthotopic liver xenotransplantation from pig to baboon using polytransgenic pig livers (CD55, CD59, and H-transferase). Transplant. Proc. 37(9), 4103-4106 (2005). (Pubitemid 43015264)
31. Phelps CJ, Koike C, Vaught TD et al. Production of α1,3- galactosyltransferasedeficient pigs. Science 299(5605), 411-414 (2003).
32. Yamada K, Yazawa K, Shimizu A et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of α1,3- galactosyltransferase geneknockout donors and the cotransplantation of vascularized thymic tissue. Nat. Med. 11(1), 32-34 (2005). (Pubitemid 40215834)
33. Kuwaki K, Tseng YL, Dor FJ et al. Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat. Med. 11(1), 29-31 (2005). (Pubitemid 40215833)
34. Tseng YL, Kuwaki K, Dor FJ et al. α1,3-Galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months. Transplantation 80(10), 1493-1500 (2005). (Pubitemid 41803633)
35. Robson SC, Cooper DK, d'Apice AJ. Disordered regulation of coagulation and platelet activation in xenotransplantation. Xenotransplantation 7(3), 166-176 (2000).
36. Shimizu A, Hisashi Y, Kuwaki K et al. Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from α1,3-galactosyltransferase gene-knockout pigs in baboons. Am. J. Pathol. 172(6), 1471-1481 (2008). (Pubitemid 351793341)
37. Ekser B, Echeverri GJ, Hassett AC et al. Hepatic function after genetically engineered pig liver transplantation in baboons. Transplantation 90(5), 483-493 (2010).
38. Tector AJ, Berho M, Fridell JA et al. Rejection of pig liver xenografts in patients with liver failure: implications for xenotransplantation. Liver Transpl. 7(2), 82-89 (2001). (Pubitemid 32166511)
39. Tector AJ, Fridell JA, Elias N et al. Aberrations in hemostasis and coagulation in untreated discordant hepatic xenotransplantation: studies in the dog-to-pig model. Liver Transpl. 8(2), 153-159 (2002). (Pubitemid 34202144)
40. Kirk AD, Morrell CN, Baldwin WM 3rd. Platelets influence vascularized organ transplants from start to finish. Am. J. Transplant. 9(1), 14-22 (2009).
41. Ezzelarab M, Ekser B, Gridelli B, Iwase H, Ayares D, Cooper DK. Thrombocytopenia after pig-to-baboon liver xenotransplantation: where do platelets go? Xenotransplantation 18(6), 320-327 (2011).
42. Ekser B, Lin CC, Long C et al. Potential factors influencing the development of thrombocytopenia and consumptive coagulopathy after genetically-modified pig liver xenotransplantation. Transplant Int. 25(8), 882-896 (2012).
43. Burlak C, Paris LL, Chihara RK et al. The fate of human platelets perfused through the pig liver: implications for xenotransplantation. Xenotransplantation 17(5), 350-361 (2010).
44. Rees MA, Butler AJ, Davies HF et al. Porcine livers perfused with human blood mount a graft-versus-"host" reaction. Transplantation 73(9), 1460-1467 (2002). (Pubitemid 34547468)
45. Rees MA, Butler AJ, Chavez-Cartaya G et al. Prolonged function of extracorporeal hDAF transgenic pig livers perfused with human blood. Transplantation 73(8), 1194-1202 (2002). (Pubitemid 34454263)
46. Rees MA, Butler AJ, Negus MC, Davies HF, Friend PJ. Classical pathway complement destruction is not responsible for the loss of human erythrocytes during porcine liver perfusion. Transplantation 77(9), 1416-1423 (2004). (Pubitemid 38668438)
47. Burdorf L, Barth RN, Zhang T et al. Pilot evaluation of anti-GPIb effects on platelet sequestration in an ex vivo xenogeneic pig liver perfusion model. Transplantation 90(Suppl. 327), Abstract TTS 3132 (2010).
48. Paris LL, Chihara RK, Sidner RA, Tector AJ, Burlak C. Differences in human and porcine platelet oligosaccharides may influence phagocytosis by liver sinusoidal cells in vitro. Xenotransplantation 19(1), 31-39 (2012).
49. Paris LL, Chihara RK, Reyes LM et al. ASGR1 expressed by porcine enriched liver sinusoidal endothelial cells mediates human platelet phagocytosis in vitro. Xenotransplantation 18(4), 245-251 (2011).
50. Chihara RK, Paris LL, Reyes LM et al. Primary porcine Kupffer cell phagocytosis of human platelets involves the CD18 receptor. Transplantation 92(7), 739-744 (2011).
51. Peng QBL, Yeh H, Enjoji K et al. Integrin-dependent baboon platelet activation and phagocytosis by porcine hepatocytes and endothelial cells. Xenotransplantation 18, 287 (2011).
52. Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG. Desensitization of G protein-coupled receptors and neuronal functions. Annu. Rev. Neurosci. 27, 107-144 (2004). (Pubitemid 39050399)
53. Munro JM, Pober JS, Cotran RS. Tumor necrosis factor and interferon-γ induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Papio anubis. Am. J. Pathol. 135(1), 121-133 (1989). (Pubitemid 19228997)
54. Bach FH, Robson SC, Ferran C et al. Endothelial cell activation and thromboregulation during xenograft rejection. Immunol. Rev. 141, 5-30 (1994). (Pubitemid 24333756)
55. Schulte am Esch J 2nd, Cruz MA, Siegel JB, Anrather J, Robson SC. Activation of human platelets by the membrane-expressed A1 domain of von Willebrand factor. Blood 90, 4425-4437 (1997). (Pubitemid 27508448)
56. Schulte am Esch J 2nd, Robson SC, Knoefel WT, Eisenberger CF, Peiper M, Rogiers X. Impact of O-linked glycosylation of the VWF-A1-domain flanking regions on platelet interaction. Br. J. Haematol. 128, 82-90 (2005).
57. Cantu E, Balsara KR, Li B et al. Prolonged function of macrophage, von Willebrand factor-deficient porcine pulmonary xenografts. Am. J. Transplant. 7(1), 66-75 (2007). (Pubitemid 44952857)
58. Pascher Sauer IM, Hammer C, Gerlach JC, Neuhaus P. Extracorporeal liver perfusion as hepatic assist in acute liver failure: A review of world experience. Xenotransplantation 9, 309-324 (2002). (Pubitemid 36358942)
59. Rees MA, Butler AJ, Brons IG, Negus MC, Skepper JN, Friend PJ. Evidence of macrophage receptors capable of direct recognition of xenogeneic epitopes without opsonization. Xenotransplantation 12(1), 13-19 (2005). (Pubitemid 40105144)
60. Rees MA. A novel role for lectins in xenotransplantation. Xenotransplantation 12, 7-12 (2005). (Pubitemid 40105143)
61. Burlak C, Twining LM, Rees MA. Terminal sialic acid residues on human glycophorin A are recognized by porcine kupffer cells. Transplantation 80(3), 344-352 (2005). (Pubitemid 41129963)
62. Brock LG, Delputte PL, Waldman JP, Nauwynck HJ, Rees MA. Porcine sialoadhesin: A newly identified xenogeneic innate immune receptor. Am. J. Transplant. doi: 10.1111/j.1600-6143.2012.04247.x. (2012) (Epub ahead of print).
63. Waldman JP, Vogel T, Friend P, Rees MA. Blocking porcine sialoadhesin improves extracorporeal porcine liver xenoperfusion. Xenotransplantation 18, abstract #130 (2011).
64. Hara H, Gridelli B, Lin YJ, Marcos A, Cooper DK. Liver xenografts for the treatment of acute liver failure: clinical and experimental experience and remaining immunologic barriers. Liver Transpl. 14(4), 425-434 (2008). (Pubitemid 351524397)
65. Hara H, Campanile N, Tai HC et al. An in vitro model of pig liver xenotransplantation-pig complement is associated with reduced lysis of wild-type and genetically modified pig cells. Xenotransplantation 17(5), 370-378 (2010).
66. Schulte am Esch J 2nd, Robson SC, Knoefel WT, Hosch SB, Rogiers X. O-linked glycosylation and functional incompatibility of porcine von Willebrand factor for human platelet GPIb receptors. Xenotransplantation 12, 30-37 (2005). (Pubitemid 40105146)
67. Rumjantseva V, Grewal PK, Wandall HH et al. Dual roles for hepatic lectin receptors in the clearance of chilled platelets. Nat. Med. 15(11), 1273-1280 (2009).
68. Ekser B, Ezzelarab M, Hara H et al. Clinical xenotransplantation: The next medical revolution? Lancet 379(9816), 672-683 (2012).
69. Takenaka K, Prasolava TK, Wang JC et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat. Immunol. 8(12), 1313-1323 (2007). (Pubitemid 350138972)
70. Paris LL, Reyes LM, Tector AJ. SIRPα interspecies incompatibilities lead to xenogeneic phagocytosis of platelets by liver cells. Xenotransplantation 18, abstract #411 (2011).
71. Ide K, Wang H, Tahara H et al. Role for CD47-SIRP-α signaling in xenograft rejection by macrophages. Proc. Natl Acad. Sci. U.S.A. 104(12), 5062-5066 (2007). (Pubitemid 47186176)
72. Yang YG. CD47 in xenograft rejection and tolerance induction. Xenotransplantation 17(4), 267-273 (2010).
73. Subramanian S, Tsai R, Discher DE. The 'metabolon,' CD47, and the 'phagocytic synapse': molecular co-localization and species divergence. Transfus. Clin. Biol. 13(1-2), 31-38 (2006).
74. Tena A, Vallabhajosyula P, Hawley RJ, Griesemer A, Yamada K, Sachs DH. Quantification of baboon thymopoiesis in porcine thymokidney xenografts by the signal-joining T-cell receptor excision circle assay. Transplantation 91(6), 639-644 (2011).
75. Isenberg JS, Romeo MJ, Abu-Asab M et al. Increasing survival of ischemic tissue by targeting CD47. Circ. Res. 100(5), 712-720 (2007). (Pubitemid 46594886)
76. Isenberg JS, Ridnour LA, Dimitry J, Frazier WA, Wink DA, Roberts DD. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J. Biol. Chem. 281(36), 26069-26080 (2006). (Pubitemid 44401813)
77. Isenberg JS, Romeo MJ, Yu C et al. Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling. Blood 111(2), 613-623 (2008).
78. Lamy L, Foussat A, Brown EJ, Bornstein P, Ticchioni M, Bernard A. Interactions between CD47 and thrombospondin reduce inflammation. J. Immunol. 178(9), 5930-5939 (2007). (Pubitemid 46674390)
79. Esmon CT, Owen WG. The discovery of thrombomodulin. J. Thromb. Haemost. 2(2), 209-213 (2004). (Pubitemid 40186031)
80. Roussel JC, Moran CJ, Salvaris EJ, Nandurkar HH, d'Apice AJ, Cowan PJ. Pig thrombomodulin binds human thrombin but is a poor cofactor for activation of human protein C and TAFI. Am. J. Transplant. 8(6), 1101-1112 (2008). (Pubitemid 351766700)
81. Siegel JB, Grey ST, Lesnikoski BA et al. Xenogeneic endothelial cells activate human prothrombin. Transplantation 64(6), 888-896 (1997). (Pubitemid 27422273)
82. Kopp CW, Grey ST, Siegel JB et al. Expression of human thrombomodulin cofactor activity in porcine endothelial cells. Transplantation 66(2), 244-251 (1998). (Pubitemid 28370009)
83. Ayares D, Phelps C, Vaught T et al. Multi-transgenic pigs for vascularized pig organ xenografts. Xenotransplantation 18, abstract 119 (2011).
84. Iwamoto M, Yazaki S, Onishi A et al. Successful production and breeding of cloned pigs expressing human thrombomodulin in endothelial cells. Xenotransplantation 18 Abstract 125 (2011).
85. Klymiuk N, Wuensch A, Kurome M et al. GalT-KO/CD46/hTM triple-transgenic donor animals for pig-to-baboon heart transplantation. Xenotransplantation 18, abstract #126 (2011).
86. Salvaris E, Fisicaro N, Harrison S et al. Expression of human thrombomodulin in GTKO/hCD55-CD59-HTF pigs. Xenotransplantation 18, abstract #513 (2011).
87. Miwa Y, Yamamoto K, Onishi A et al. Potential value of human thrombomodulin and DAF expression for coagulation control in pig-to-human xenotransplantation. Xenotransplantation 17(1), 26-37 (2010).
88. Crikis S, Zhang XM, Dezfouli S et al. Anti-inflammatory and anticoagulant effects of transgenic expression of human thrombomodulin in mice. Am. J. Transplant. 10(2), 242-250 (2010).
89. d'Apice AJ, Cowan PJ. Xenotransplantation: The next generation of engineered animals. Transpl. Immunol. 21(2), 111-115 (2009).
90. Esmon CT. The endothelial protein C receptor. Curr. Opin. Hematol. 13(5), 382-385 (2006). (Pubitemid 44168461)
91. Cooper DK, Ekser B, Burlak C et al. Clinical lung xenotransplantation - what donor genetic modifications may be necessary? Xenotransplantation 19(3), 144-158 (2012).
92. Lin CC, Ezzelarab M, Shapiro R et al. Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation. Am. J. Transplant. 10(7), 1556-1568 (2010).
93. Kopp CW, Siegel JB, Hancock WW et al. Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors. Transplantation 63(5), 749-758 (1997). (Pubitemid 27132211)
94. Lee KF, Salvaris EJ, Roussel JC, Robson SC, d'Apice AJ, Cowan PJ. Recombinant pig TFPI efficiently regulates human tissue factor pathways. Xenotransplantation 15(3), 191-197 (2008). (Pubitemid 352000255)
95. Chen D, Giannopoulos K, Shiels PG et al. Inhibition of intravascular thrombosis in murine endotoxemia by targeted expression of hirudin and tissue factor pathway inhibitor analogs to activated endothelium. Blood 104(5), 1344-1349 (2004). (Pubitemid 39166509)
96. Phelps C, Vaught T, Ball S et al. Multitransgenic pigs designed for xenoislet transplants. Xenotransplantation 16 Abstract-IXA-O-7.3 (2009).
97. Kaczmarek E, Koziak K, Sévigny J et al. Identification and characterization of CD39/vascular ATP diphosphohydrolase. J. Biol. Chem. 271(51), 33116-33122 (1996). (Pubitemid 27008752)
98. Wheeler DG, Joseph ME, Mahamud SD et al. Transgenic swine: expression of human CD39 protects against myocardial injury. J. Mol. Cell. Cardiol. 52(5), 958-961 (2012).
99. Dwyer KM, Robson SC, Nandurkar HH et al. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J. Clin. Invest. 113(10), 1440-1446 (2004). (Pubitemid 39071699)
100. Dwyer KM, Mysore TB, Crikis S et al. The transgenic expression of human CD39 on murine islets inhibits clotting of human blood. Transplantation 82(3), 428-432 (2006). (Pubitemid 44223045)
101. Köhler D, Eckle T, Faigle M et al. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury. Circulation 116(16), 1784-1794 (2007). (Pubitemid 350287103)
102. Crikis S, Lu B, Murray-Segal LM et al. Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury. Am. J. Transplant. 10(12), 2586-2595 (2010).
103. Le Bas-Bernardet S, Branchereau J, Tillou X et al. Porcine galactosyltransferase knock-out transgenic for human CD55, CD59, CD39 kidneys are actually rejected by baboons despite plasma/B cells and complement blockade. Xenotransplantation 18, abstract #556 (2011).
104. Le Bas-Bernardet S, Poirier N, Tillou X et al. Preformed non-Gal antibodies are highly cytotoxic even against Galactosyltransferase knockout, human CD55, CD59, CD39 transgenic pig organs in a model of kidney transplantation into baboons. Xenotransplantation 43(9), 3426-3430 (2011).
105. Schneider MK, Ghielmetti M, Rhyner DM, Antsiferova MA, Seebach JD. Human leukocyte transmigration across Galα(1,3) Gal-negative porcine endothelium is regulated by human CD18 and CD99. Transplantation 87(4), 491-499 (2009).
106. Puga Yung G, Schneider MK, Seebach JD. Immune responses to α-1,3 galactosyltransferase knockout pigs. Curr. Opin. Organ Transplant. 14(2), 154-160 (2009).
107. Holgersson J, Gustafsson A, Breimer ME. Characteristics of protein-carbohydrate interactions as a basis for developing novel carbohydrate-based antirejection therapies. Immunol. Cell Biol. 83(6), 694-708 (2005). (Pubitemid 43083102)